Sponsor

Scios, Inc.

Clinical research sponsor

Published trials32
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

32 shown
A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart FailureNCT00475852 · lead sponsor · 2007-05-01
COMPLETED
Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMACNCT00338455 · lead sponsor · 2006-09-01
TERMINATED
SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving MethotrexateNCT00089921 · lead sponsor · 2004-07-01
COMPLETED
Registry for Acute Decompensated Heart Failure Patients Admitted to the ERNCT00364325 · lead sponsor · 2004-07-01
COMPLETED
A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart FailureNCT00091520 · lead sponsor · 2004-04-01
COMPLETED
Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPANCT00653042 · lead sponsor · 2004-03-01
COMPLETED
Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSSNCT00652652 · lead sponsor · 2003-03-01
COMPLETED
Longitudinal Registry for Advanced Heart Failure PatientsNCT00364416 · lead sponsor · 2002-10-01
COMPLETED
FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.NCT00270361 · lead sponsor · 2001-12-01
COMPLETED
Registry for Acute Decompensated Heart Failure PatientsNCT00366639 · lead sponsor · 2001-10-01
COMPLETED
Heart Failure RegistryNCT00530426 · lead sponsor · 2001-09-01
COMPLETED
A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care TherapyNCT00270387 · lead sponsor · 2001-01-01
COMPLETED
A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.NCT00270374 · lead sponsor · 1999-10-01
COMPLETED
A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart FailureNCT00270400 · lead sponsor · 1998-08-01
COMPLETED
A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood VesselsNCT00271557 · lead sponsor · 1997-01-01
COMPLETED
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at RestNCT00288730 · lead sponsor · 1996-10-01
COMPLETED
Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving MethotrexateNCT00043732 · lead sponsor
COMPLETED
A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid ArthritisNCT00508768 · lead sponsor
COMPLETED
An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)NCT00530361 · lead sponsor
WITHDRAWN
Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EFNCT00505791 · collaborator · 2007-08-01
WITHDRAWN
BNP Therapy Observation Unit Outcomes STudy (BOOST)NCT00453453 · collaborator · 2007-03-01
TERMINATED
Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial RelaxationNCT00204984 · collaborator · 2005-05-01
COMPLETED
Catheterization Laboratory Study: Acute Responses in Diastolic Heart FailureNCT00204945 · collaborator · 2005-02-01
COMPLETED
BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)NCT00186329 · collaborator · 2004-03-01
COMPLETED
Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency DepartmentNCT00559338 · collaborator · 2003-12-01
COMPLETED
Nesiritide in Chronic Heart FailureNCT00145873 · collaborator · 2003-08-01
TERMINATED
Nesiritide and Vo2 Max in Heart Failure PatientsNCT00240084 · collaborator · 2003-07-01
COMPLETED
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal DysfunctionNCT00119691 · collaborator · 2003-04-01
COMPLETED
Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart FailureNCT00170183 · collaborator · 2003-03-01
COMPLETED
BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.NCT00252200 · collaborator · 2003-03-01
COMPLETED
Study of Nesiritide in Diastolic Heart Failure.NCT00309868 · collaborator · 2002-12-01
COMPLETED
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart FailureNCT00252187 · collaborator · 2000-01-01
COMPLETED

Sponsor roles

lead sponsor19
collaborator13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.